Back to top

Corporate Summary


•    AOL (NYSE:AOL) reported a loss Q2 EPS of $0.11, against the Zacks Consensus Estimate of a profit of $0.02 per share. Revenues for the quarter declined by 8% to $542.2 million

•    Snyder's-Lance (NASDAQ:LNCE) posted Q2 EPS of $0.16, ex-items, missing the Zacks Consensus Estimate of $0.18 per share. Revenues for the quarter increased by 75.7% year-over-year to $413.0 million

•    ReneSola (NYSE:SOL) posted Q2 EPS of $0.02, missing consensus estimates of $0.16 per share. Revenues declined 1.8% year-over-year to $249.3 million against consensus estimates of $147.6 million

•    Sempra Energy (NYSE:SRE) reported adjusted Q2 EPS of $0.97, which came in lower than the Zacks Consensus Estimate of $1.00 per share. Revenues for the quarter increased 21% year-over-year to $2.42 billion

•    ATP Oil & Gas (NASDAQ:ATPG) posted a Q2 loss of $1.11 per share, beating the Zacks Consensus Estimate for a loss of $0.35 per share. Revenues increased 71% year-over-year to $172.9 million

•    GeoResources, Inc. (NASDAQ:GEOI) reported Q2 EPS of $0.31, surpassing the Zacks Consensus Estimate of $0.29 per share. Revenues for the quarter increased 17% year-over-year to $30.9 million

•    Share prices of Booz Allen Hamilton Holding Corp. (NYSE:BAH) rose 8.18% after the company posted s first quarter earnings figures that came in above estimates

•    Medical-safety products maker CareFusion Corporation.’s (NYSE:CFN) share prices increased 9.97% after the company reported fourth-quarter earnings results that topped forecasts late on Monday

•    Analysts at Argus Research raised their rating on shares of CBS Corporation (NYSE:CBS) from "Hold" rating to "Buy" rating. Following this development, share prices of the television network owner jumped 14.88% to close at $24.48

•    Medical device maker Stereotaxis, Inc. (NASDAQ:STXS) announced late on Monday that its chief financial officer would be leaving the company. The company for the time being also suspended its outlook for the fiscal 2011. Following this development, shares of the company plunged 57.54% to close at $1.19

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
ERBA DIAGNO… ERB 3.79 +6.76%
STAR BULK C… SBLK 13.96 +3.18%
BANCO DO BR… BDORY 14.20 +1.79%
GREEN PLAIN… GPRE 44.54 +1.67%
WEATHERFORD… WFT 23.31 +1.64%